Correlation Between Foghorn Therapeutics and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Foghorn Therapeutics and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Cadrenal Therapeutics,.
Diversification Opportunities for Foghorn Therapeutics and Cadrenal Therapeutics,
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Foghorn and Cadrenal is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Cadrenal Therapeutics,
Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 0.63 times more return on investment than Cadrenal Therapeutics,. However, Foghorn Therapeutics is 1.58 times less risky than Cadrenal Therapeutics,. It trades about -0.03 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest 817.00 in Foghorn Therapeutics on August 30, 2024 and sell it today you would lose (38.00) from holding Foghorn Therapeutics or give up 4.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Foghorn Therapeutics |
| Cadrenal Therapeutics, |
Foghorn Therapeutics and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Cadrenal Therapeutics,
The main advantage of trading using opposite Foghorn Therapeutics and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Foghorn Therapeutics vs. Ikena Oncology | Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |